Breast cancer prevention in high-risk women
MA Thorat, R Balasubramanian - … Practice & Research Clinical Obstetrics & …, 2020 - Elsevier
… breast cancer burden [2]. In this review of evidence and approaches … breast cancer prevention
in high-risk women, we discuss breast cancer risk factors and genetic predisposition, risk …
in high-risk women, we discuss breast cancer risk factors and genetic predisposition, risk …
[HTML][HTML] Definition of high-risk early hormone-positive HER2− Negative breast cancer: a consensus review
M Garutti, G Griguolo, A Botticelli, G Buzzatti… - Cancers, 2022 - mdpi.com
… breast cancer, estimating the risk of relapse of breast cancer on an individual basis is still
challenging. The IRIDE (high risk definition in breast cancer) … early breast cancer relapse. This …
challenging. The IRIDE (high risk definition in breast cancer) … early breast cancer relapse. This …
… exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and …
… For studies involving women at high risk of breast cancer, given the small number of … this
is accompanied by a reduction in lean mass in women at high risk of breast cancer. Previous …
is accompanied by a reduction in lean mass in women at high risk of breast cancer. Previous …
[HTML][HTML] Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics
DR Nelson, J Brown, A Morikawa, M Method - PLoS One, 2022 - journals.plos.org
… in breast cancer-specific mortality risk factors … breast cancer-specific mortality by subtype.
Additional objectives were to describe the incidence of monarchE clinicopathological high-risk …
Additional objectives were to describe the incidence of monarchE clinicopathological high-risk …
Physical activity before, during, and after chemotherapy for high-risk breast cancer: relationships with survival
…, W Barlow, KM Kelly, CA DeNysschen… - … the National Cancer …, 2021 - academic.oup.com
… and Cancer Prognosis Study (DELCaP) was a questionnaire-based study ancillary to a
breast cancer … of women with high-risk, pathologic stage I to III breast cancer at multiple times …
breast cancer … of women with high-risk, pathologic stage I to III breast cancer at multiple times …
[HTML][HTML] Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, SM Tolaney… - Annals of …, 2021 - Elsevier
… , high-risk early breast cancer at the second interim analysis, however follow-up was limited.
Here, we present results of the prespecified primary outcome analysis and an additional …
Here, we present results of the prespecified primary outcome analysis and an additional …
Palbociclib for residual high-risk invasive HR-positive and HER2-negative early breast cancer—the penelope-B trial
S Loibl, F Marmé, M Martin, M Untch… - Journal of clinical …, 2021 - ascopubs.org
… in first-line and pretreated metastatic breast cancer, improves … disease after NACT who are
at high risk of relapse. Based on … − breast cancer patients with residual disease and high risk …
at high risk of relapse. Based on … − breast cancer patients with residual disease and high risk …
Assessment of residual cancer burden and event-free survival in neoadjuvant treatment for high-risk breast cancer: an analysis of data from the I-SPY2 randomized …
WF Symmans, C Yau, YY Chen, R Balassanian… - JAMA …, 2021 - jamanetwork.com
… women with stage 2/3 breast cancer at high risk of early recurrence. … if real-time Bayesian
statistical modeling predicts a high … across high-risk phenotypic subtypes of breast cancer and …
statistical modeling predicts a high … across high-risk phenotypic subtypes of breast cancer and …
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned …
SRD Johnston, M Toi, J O'Shaughnessy… - The lancet …, 2023 - thelancet.com
… , node-positive, early breast cancer at a high risk of recurrence with an Eastern Cooperative
… High-risk disease was defined as either four or more positive axillary lymph nodes, or …
… High-risk disease was defined as either four or more positive axillary lymph nodes, or …
Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2−, node-positive, high-risk, early breast cancer (monarchE)
SRD Johnston, N Harbeck, R Hegg, M Toi… - Journal of Clinical …, 2020 - ascopubs.org
… cancer, and, after a protocol amendment, patients with inflammatory breast cancer, were
excluded. Patients who had received treatment with ET for breast cancer prevention, raloxifene, …
excluded. Patients who had received treatment with ET for breast cancer prevention, raloxifene, …
相关搜索
- negative breast cancer high risk
- early breast cancer
- breast cancer survivors
- breast cancer physical activity
- breast cancer prevention
- breast cancer hormone receptor
- breast cancer diagnosis
- initial therapy for advanced breast cancer
- breast cancer neoadjuvant therapy
- breast cancer recurrence
- breast cancer estrogen receptor
- breast cancer postmenopausal women
- breast cancer women with hr her2
- breast cancer neoadjuvant chemotherapy
- high risk breast cancer neoadjuvant treatment
- breast cancer endocrine therapy